HR 1904: National Ovarian Cancer Awareness Day at the state capitol; September 16, 2026; recognize

This resolution from the Georgia House of Representatives designates September 16, 2026, as National Ovarian Cancer Awareness Day at the state capitol. It does not change any law or create any program. Instead, it lays out a long series of factual findings about ovarian cancer, including its mortality rate, survival statistics, racial disparities in diagnosis and outcomes, the lack of a reliable early detection test, common symptoms, and the role of genetic factors like BRCA gene mutations. The resolution formally states that House members recognize the day, and it directs the Clerk of the House to prepare copies of the resolution for distribution to the public and press. It has no funding attached and does not require any state agency to take action beyond this recognition and distribution.

• Formally designates September 16, 2026, as National Ovarian Cancer Awareness Day at the Georgia state capitol.
• Directs the Clerk of the House of Representatives to prepare and distribute copies of the resolution to the public and press.
• Creates no new law, funding, agency requirement, or penalty; it is a symbolic recognition rather than a binding policy change.

The resolution primarily affects public awareness efforts around ovarian cancer in Georgia. It references women generally, and specifically Black women, low-income women, rural women, and women in the military, as groups facing higher risks or worse outcomes, though the resolution itself creates no obligations for any of these groups.

While the resolution carries no legal force, it puts the Georgia House on record highlighting gaps in ovarian cancer detection, disparities in outcomes for Black women, and the value of genetic testing, which could support broader public awareness or advocacy efforts.

• The resolving clause recognizes September 16, 2026, as National Ovarian Cancer Awareness Day at the state capitol.
• A further resolution directs the Clerk of the House to make copies available for distribution to the public and press.
• The whereas clauses cite statistics on survival rates, racial disparities, symptoms, and genetic risk factors like BRCA mutations, providing background rather than binding requirements.

1. 2026-03-25House Read and Adopted (Cámara de Representantes)
2. 2026-03-25House First Readers (Cámara de Representantes)
3. 2026-03-25House Hopper (Cámara de Representantes)

• Lisa Campbell (D, HD-035)Patrocinador principal

• ovarian cancer awareness
• women's health
• cancer research
• health disparities